EI
PACB icon

Ethic Inc’s Pacific Biosciences PACB Stock Holding History

Ethic Inc’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,383
Closed -$65.2K – 1204
2024
Q3 		$65.2K Buy
+17,383
New +$28.6K ﹤0.01% 1055
2024
Q2 		– Sell
-17,383
Closed -$65.2K – 1163
2024
Q1 		$65.2K Buy
17,383
+564
+3% +$3.3K ﹤0.01% 1055
2023
Q4 		$165K Sell
16,819
-665
-4% -$5.44K ﹤0.01% 996
2023
Q3 		$146K Sell
17,484
-182
-1% -$2.08K 0.01% 965
2023
Q2 		$235K Buy
17,666
+326
+2% +$3.96K 0.01% 866
2023
Q1 		$201K Sell
17,340
-241
-1% -$2.4K 0.01% 895
2022
Q4 		$144K Buy
+17,581
New +$151K 0.01% 857

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ethic Inc's PACB Position: Q4 2024 in Review

Ethic Inc sold out of Pacific Biosciences (PACB) in Q4 2024, closing a stake of 17,383 shares — an estimated $65.2K sold.

Ethic Inc first reported a position in PACB in Q4 2022 and held it in 7 quarters. The position peaked at $235K in Q2 2023. 226 funds tracked by Wall St. Rank hold PACB as of Q4 2024.

  • Ethic Inc reported no remaining Pacific Biosciences position as of Q4 2024 after selling out during the quarter.
  • Ethic Inc sold 17,383 Pacific Biosciences shares in Q4 2024, an estimated $65.2K.
  • Ethic Inc first reported a position in Pacific Biosciences in Q4 2022 and held it in 7 quarters.
  • Ethic Inc's Pacific Biosciences position peaked at $235K in Q2 2023.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2024.

Based on Ethic Inc's 13F filing for Q4 2024, filed 14 Feb 2025.